Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
7.70
+0.23 (3.08%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Sight Sciences Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 83.38 | 77.36 | 79.87 | 81.06 | 71.33 | 48.96 |
Revenue Growth | 9.27% | -3.13% | -1.47% | 13.63% | 45.70% | 77.12% |
Gross Profit Gross Profit Growth | 73.34 | 66.67 | 68.29 | 69.18 | 58.97 | 40.35 |
Operating Income Operating Income Growth | -27.88 | -37.1 | -50.53 | -57.27 | -83.95 | -51.48 |
Net Income Net Income Growth | -29.76 | -38.43 | -51.51 | -55.55 | -86.24 | -62.96 |
Earnings Per Share EPS Growth | -0.56 | -0.74 | -1.03 | -1.14 | -1.80 | -2.36 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Interventional Glaucoma Interventional Glaucoma Growth | 78.44 | 75.72 | 75.9 | 74.31 | 65.59 | 46.5 |
Interventional Dry Eye Interventional Dry Eye Growth | 4.94 | 1.64 | 3.96 | 6.75 | 5.74 | 2.46 |
Total Total Growth | 83.38 | 77.36 | 79.87 | 81.06 | 71.33 | 48.96 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 79.75 | 91.97 | 120.36 | 138.13 | 185 | 260.69 |
Total Debt Total Debt Growth | 40.78 | 40.3 | 39.36 | 33.93 | 33.31 | 32.66 |
Net Cash (Debt) Net Cash Growth | 38.98 | 51.67 | 81 | 104.2 | 151.69 | 228.03 |
Net Cash Growth | -36.81% | -36.22% | -22.26% | -31.30% | -33.48% | 671.52% |
Net Cash Per Share Net Cash Per Share Growth | 0.73 | 0.99 | 1.62 | 2.14 | 3.17 | 8.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -23.24 | -29.69 | -22.35 | -47.18 | -75.97 | -52.54 |
Capital Expenditures CapEx Growth | -0.09 | -0.22 | -0.39 | -0.79 | -0.97 | -0.81 |
Free Cash Flow Free Cash Flow Growth | -23.33 | -29.92 | -22.74 | -47.98 | -76.94 | -53.35 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 87.96% | 86.17% | 85.50% | 85.34% | 82.67% | 82.41% |
Operating Margin | -33.43% | -47.95% | -63.27% | -70.66% | -117.70% | -105.15% |
Pretax Margin | -35.73% | -49.66% | -64.20% | -68.39% | -120.84% | -128.22% |
Profit Margin | -35.69% | -49.67% | -64.49% | -68.53% | -120.90% | -128.60% |
FCF Margin | -27.98% | -38.67% | -28.47% | -59.19% | -107.86% | -108.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 5.09 | 5.48 | 2.32 | 3.13 | 8.27 | 17.05 |